CN106540046A - A kind of vagina antibiosis pharmaceutical gel - Google Patents

A kind of vagina antibiosis pharmaceutical gel Download PDF

Info

Publication number
CN106540046A
CN106540046A CN201611194297.5A CN201611194297A CN106540046A CN 106540046 A CN106540046 A CN 106540046A CN 201611194297 A CN201611194297 A CN 201611194297A CN 106540046 A CN106540046 A CN 106540046A
Authority
CN
China
Prior art keywords
weight portion
weight portions
vagina
pharmaceutical gel
antibiosis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201611194297.5A
Other languages
Chinese (zh)
Inventor
甘起伍
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201611194297.5A priority Critical patent/CN106540046A/en
Publication of CN106540046A publication Critical patent/CN106540046A/en
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/48Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/489Sophora, e.g. necklacepod or mamani
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716Glucans
    • A61K31/722Chitin, chitosan
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/23Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A61K36/234Cnidium (snowparsley)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/28Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A61K36/286Carthamus (distaff thistle)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/61Myrtaceae (Myrtle family), e.g. teatree or eucalyptus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/889Arecaceae, Palmae or Palmaceae (Palm family), e.g. date or coconut palm or palmetto
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/896Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0034Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/06Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Gynecology & Obstetrics (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Inorganic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The present invention provides a kind of vagina antibiosis pharmaceutical gel, is made up of the raw material of following weight portion:68 weight portion of kuh-seng, 10 12 weight portion of safflower, 7 13 weight portion of dragon's blood, 46 weight portion of modification of chitosan, 24 weight portion of Polycarbophil, 24 weight portion of tea tree ethereal oil, 36 weight portion of triethanolamine, 24 weight portion of emulsifying agent, 69 weight portion of Carbomer, 8 10 weight portion of frutus cnidii, 12 weight portion of methyl p-hydroxybenzoate;Compared with prior art, the present invention has following beneficial effect:Can quick anti-inflammatory anti-itch, dispelling abnormal flavor, multiple pathogens cross-infection in blocking sexual life; moist yin-nourishing, nurses one's health flora, balancing alkalinity acidity; protection and reparation vagina mucosa; contraction is compacted mobile pleat, increases elasticity and susceptibility, real meaning from basic conditioning; lift Reproductive Performance; prevention of inflammation recurrent exerbation, recovery occurs without treatment, while physiological function can be lifted.

Description

A kind of vagina antibiosis pharmaceutical gel
Technical field
The present invention is a kind of vagina antibiosis pharmaceutical gel, belongs to pharmaceutical synthesis field.
Background technology
As social development, the life style of people and behavior are constantly changing, various gynecological diseases, such as genital tract The illness rate of infection, menstrual disorder and mammary gland disease etc. is gradually increasing.Gynecological infectious diseases are used as a class common disease and many Morbidity, particularly colpomycosis, cervical erosion and the senile vahinitis incidence of disease are very high, and various chronic cervical diseases are even more Vast female friend is annoying throughout the year.
For example, pure VVC (SVVC) is a kind of excessively numerous in intravaginal by candidiasis The gynaecology's infectious diseases in genital tract grown and cause, the most common are candida albicans infection, and illness rate accounts for Childbearing woman Woman 5%.SVVC is easily recurred before and after menstrual period, and the recurrence rate after treating is 5%~10%.Research recently (Liu Chaohui, Liao Qinping. Chinese vagina infection diagnosis of disease strategy [M]. Beijing:People's Medical Officer Press, 2009.) shows, SVVC's sends out Raw disorderly with intravaginal microenvironment and imbalance has a direct relation, intravaginal sour environment is stable with destruction that is balancing be it is main because Element.As Candida albicans is conditioned pathogen, its optimum pH value of growth is 5.5, when the faintly acid of vagina is changed into After pH5.5, the bacterium amount reproduction causes vaginitis symptom.In recent years relevant report also mentions vagina environment with colpitic pass System, but it is often not enough.Such as with alkaline solution rinse (Yao Caidi, Cui Mingxia. external application mildew making plain piece and vaginal scouring treatment The clinical observation [J] of VVC. Gansu medicine, 2010.), though temporarily changing internal pH value, make white Environment of the candida albicans in growing, but due to destroying the weakly acidic environment of normal vagina, it is easily caused infection.
For Gynecological cervical and the early treatment of vaginal disease, general way is remained and uses washing lotion, to change bacterium In the growing environment of vagina.But various washing lotions can also kill the bacterium vaginae beneficial to body while germ is killed, break Bad intravaginal acid-base balance environment, Long-Time Service will substantially reduce immunity, increase the chance of bacteria infection again.Also A little oral medications for gynaecological imflammation, but these oral medications are that menses liquid is recycled into vagina position kill bacterium, are risen The effect time is slower, needs long-term taking effective, and toxic and side effect is big.So, the treatment of Gynecological cervical and vaginal disease is excellent Local application is selected, but, existing vagina externally applied drug bactericidal effect is poor, and excitant is big, easily repeatedly, there is also allergic Phenomenon, therapeutic effect is preferable not to the utmost.
Above-mentioned situation shows, the drug side-effect of existing treatment gynaecologic vaginal disease is big, and curative effect is not good enough, cause patient according to Bad property is stronger, is unfavorable for the wound repair of vast gynecological disease patient physiology and psychology.
The content of the invention
In view of the shortcomings of the prior art, it is an object of the present invention to provide a kind of vagina antibiosis pharmaceutical gel, with solution The problem proposed in stating background technology.
To achieve these goals, the present invention is by the following technical solutions realizing:A kind of vagina antibiosis are medicinal solidifying Glue, is made up of the raw material of following weight portion:Kuh-seng 6-8 weight portions, safflower 10-12 weight portions, dragon's blood 7-13 weight portions, be modified shell Glycan 4-6 weight portions, Polycarbophil 2-4 weight portions, tea tree ethereal oil 2-4 weight portions, triethanolamine 3-6 weight portions, emulsifying agent 2-4 Weight portion, Carbomer 6-9 weight portions, frutus cnidii 8-10 weight portions, methyl p-hydroxybenzoate 1-2 weight portions.
Further, during the emulsifying agent is lauryl sodium sulfate, tween, sapn, stearic acid and triethanolamine Mix for one or more.
Further, the tea tree ethereal oil be contained within to Meng's ethene, dipentene, limonene, cineol, sesame oil brain and Anisoxide.
Further, oxirane and ammoniacal liquor are sent in reactor, in reaction temperature 30-40 DEG C, reaction pressure Under 70.9-304kPa, carry out condensation reaction and generate monoethanolamine, diethanol amine, triethanolamine mixed liquor, the Jing at 90-120 DEG C After dehydration concentration, sending into three vacuum rectification towers carries out vacuum distillation, intercepts cut by different boiling, then can obtain three in raw material Monoethanolamine.
Further, elongated cylindrical is taken, branch, long 10~750px, the legume of 1~162.5px of diameter are often arranged at bottom The dry root of kuh-seng, removes retained root head, and size is separate, cleans, be dipped to about sixty percent it is saturating when, run through, cut sheet, be dried, put Enter in crushing container and crush, cross 50 mesh sieves, sieve to obtain kuh-seng in raw material.
Further, take orange red, floral tube is narrow thin, and tip 5 splits, and sliver is narrow linear, the safflower of flower pesticide yellow, cleans, from So dry, be dried, be put in crushing container and crush, cross 50 mesh sieves, sieve to obtain safflower in raw material.
Beneficial effects of the present invention:A kind of vagina antibiosis pharmaceutical gel of the present invention, tea tree ethereal oil is to Staphylococcus aureus Bacterium, Escherichia coli, Candida albicans are acted on 2 minutes, and bacteriostasis rate is up to 100%, it is ensured that to bacterial vaginitis and mycotic Vaginitis has most high inhibition effect.
Borneol can with heat-clearing and damp-drying drug, restrain it is antipruritic, removing toxic substances desinsection, swelling and pain relieving.
Carbomer plays drug effect uniform, control and is sustained and make as medicine frame is carried by various composition suspended dispersed in solvent With.
The gel of the present invention, can quick anti-inflammatory anti-itch, dispelling abnormal flavor, in blocking sexual life, multiple pathogens intersect and feel Contaminate, moisten yin-nourishing, nurse one's health flora, balancing alkalinity acidity, protection and reparation vagina mucosa, shrink the mobile pleat that compacts, increase elasticity And susceptibility, real meaning from basic conditioning, lift Reproductive Performance, prevention of inflammation recurrent exerbation, recovery occurs without treatment, while can be with Lift physiological function.
Specific embodiment
Technological means, creation characteristic, reached purpose and effect to make present invention realization is easy to understand, with reference to Specific embodiment, is expanded on further the present invention.
The present invention provides a kind of technical scheme:A kind of vagina antibiosis pharmaceutical gel, is made up of the raw material of following weight portion:It is bitter Ginseng 6-8 weight portions, safflower 10-12 weight portions, dragon's blood 7-13 weight portions, modification of chitosan 4-6 weight portions, Polycarbophil 2-4 weights Amount part, tea tree ethereal oil 2-4 weight portions, triethanolamine 3-6 weight portions, emulsifying agent 2-4 weight portions, Carbomer 6-9 weight portions, cnidium monnieri Sub- 8-10 weight portions, methyl p-hydroxybenzoate 1-2 weight portions.
Emulsifying agent is one or more mixing in lauryl sodium sulfate, tween, sapn, stearic acid and triethanolamine Form.
Tea tree ethereal oil is contained within to Meng's ethene, dipentene, limonene, cineol, sesame oil brain and anisoxide.
Oxirane and ammoniacal liquor are sent in reactor, in reaction temperature 30-40 DEG C, reaction pressure 70.9-304kPa Under, carry out condensation reaction and generate monoethanolamine, diethanol amine, triethanolamine mixed liquor, at 90-120 DEG C Jing after dehydration concentration, Sending into three vacuum rectification towers carries out vacuum distillation, intercepts cut by different boiling, then can obtain the triethanolamine in raw material.
Take elongated cylindrical, branch often arranged at bottom, long 10~750px, the legume kuh-seng of 1~162.5px of diameter it is dry Dry, remove retained root head, size is separate, clean, be dipped to about sixty percent it is saturating when, run through, cut sheet, be dried, be put into crushing and hold Crush in device, cross 50 mesh sieves, sieve to obtain kuh-seng in raw material.
Take orange red, floral tube is narrow thin, and tip 5 splits, and sliver is narrow linear, the safflower of flower pesticide yellow, cleans, dries naturally, does It is dry, it is put in crushing container and crushes, cross 50 mesh sieves, sieves to obtain safflower in raw material.
As one embodiment of the present of invention:Tea tree ethereal oil is made to staphylococcus aureus, Escherichia coli, Candida albicans With 2 minutes, bacteriostasis rate was up to 100%, it is ensured that to bacterial vaginitis and colpomycosis with most high inhibition effect.
Borneol can with heat-clearing and damp-drying drug, restrain it is antipruritic, removing toxic substances desinsection, swelling and pain relieving.
Carbomer plays drug effect uniform, control and is sustained and make as medicine frame is carried by various composition suspended dispersed in solvent With.
The gel of the present invention, can quick anti-inflammatory anti-itch, dispelling abnormal flavor, in blocking sexual life, multiple pathogens intersect and feel Contaminate, moisten yin-nourishing, nurse one's health flora, balancing alkalinity acidity, protection and reparation vagina mucosa, shrink the mobile pleat that compacts, increase elasticity And susceptibility, real meaning from basic conditioning, lift Reproductive Performance, prevention of inflammation recurrent exerbation, recovery occurs without treatment, while can be with Lift physiological function.
As one embodiment of the present of invention:15 rats are divided into 3 groups, respectively ipll00mg/kg inventive gels, hydrogenation Cortisone 20mg/kg and physiological saline.30 minutes after administration, in left and right foot plantar, sc2.5% formalins 0.05ml cause scorching, cause 1.3.5.7.24 hours after inflammation, for point swollen thickness of chi measurement rat foot, and compare with the swollen thickness of the foot before inflammation is caused, each medicine of calculating The foot swelling rate of thing group different time.As a result prove that inventive gel PARA FORMALDEHYDE PRILLS(91,95) foot swelling has obvious inhibiting effect, in the same manner may be used Being inferred to inventive gel has preferable anti-inflammatory effects.
As one embodiment of the present of invention:By the pharmaceutical gel of the present invention by ear of maize auxiliary, place to intravaginal, just The step of applying medicinal lotion or ointment can be completed, it is easy to use, nurse one's health from basic, lifting Reproductive Performance, prevention of inflammation recurrent exerbation, recovery occurs without treatment, Physiological function can be lifted simultaneously.
The general principle and principal character and advantages of the present invention of the present invention are had been shown and described above, for this area skill For art personnel, it is clear that the invention is not restricted to the details of above-mentioned one exemplary embodiment, and in the spirit without departing substantially from the present invention or In the case of essential characteristic, the present invention can be realized in other specific forms.Therefore, no matter from the point of view of which point, all should be by Embodiment regards exemplary as, and be it is nonrestrictive, the scope of the present invention by claims rather than on state Bright restriction, it is intended that all changes in the implication and scope of the equivalency of claim that will fall are included in the present invention It is interior.
Moreover, it will be appreciated that although this specification is been described by according to embodiment, not each embodiment is only wrapped Containing an independent technical scheme, this narrating mode of specification is only that those skilled in the art should for clarity Using specification as an entirety, the technical scheme in each embodiment can also Jing it is appropriately combined, form those skilled in the art Understandable other embodiment.

Claims (6)

1. a kind of vagina antibiosis pharmaceutical gel, it is characterised in that:It is made up of the raw material of following weight portion:Kuh-seng 6-8 weight portions, it is red Flower 10-12 weight portions, dragon's blood 7-13 weight portions, modification of chitosan 4-6 weight portions, Polycarbophil 2-4 weight portions, tea tree ethereal oil 2- 4 weight portions, triethanolamine 3-6 weight portions, emulsifying agent 2-4 weight portions, Carbomer 6-9 weight portions, frutus cnidii 8-10 weight portions are right Methyl hydroxybenzoate 1-2 weight portions.
2. a kind of vagina antibiosis pharmaceutical gel according to claim 1, it is characterised in that:The emulsifying agent is dodecyl One or more in sodium sulphate, tween, sapn, stearic acid and triethanolamine is mixed.
3. a kind of vagina antibiosis pharmaceutical gel according to claim 1, it is characterised in that:It is right that the tea tree ethereal oil is contained within Meng's ethene, dipentene, limonene, cineol, sesame oil brain and anisoxide.
4. a kind of vagina antibiosis pharmaceutical gel according to claim 1, it is characterised in that:Oxirane and ammoniacal liquor are sent Enter in reactor, under reaction temperature 30-40 DEG C, reaction pressure 70.9-304kPa, carry out condensation reaction generate monoethanolamine, Diethanol amine, triethanolamine mixed liquor, at 90-120 DEG C Jing after dehydration concentration, sending into three vacuum rectification towers carries out decompression steaming Evaporate, cut is intercepted by different boiling, then can obtain the triethanolamine in raw material.
5. a kind of vagina antibiosis pharmaceutical gel according to claim 1, it is characterised in that:Take elongated cylindrical, bottom Chang You Branch, long 10~750px, the dry root of the legume kuh-seng of 1~162.5px of diameter remove retained root head, and size is separate, Clean, be dipped to about sixty percent it is saturating when, run through, cut sheet, be dried, be put in crushing container and crush, cross 50 mesh sieves, sieve to obtain raw material In kuh-seng.
6. a kind of vagina antibiosis pharmaceutical gel according to claim 1, it is characterised in that:Take orange red, floral tube is narrow thin, first End 5 is split, and sliver is narrow linear, the safflower of flower pesticide yellow, cleans, dries naturally, is dried, and crushes, cross 50 in being put into crushing container Mesh sieve, sieves to obtain safflower in raw material.
CN201611194297.5A 2016-12-21 2016-12-21 A kind of vagina antibiosis pharmaceutical gel Pending CN106540046A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201611194297.5A CN106540046A (en) 2016-12-21 2016-12-21 A kind of vagina antibiosis pharmaceutical gel

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201611194297.5A CN106540046A (en) 2016-12-21 2016-12-21 A kind of vagina antibiosis pharmaceutical gel

Publications (1)

Publication Number Publication Date
CN106540046A true CN106540046A (en) 2017-03-29

Family

ID=58397736

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201611194297.5A Pending CN106540046A (en) 2016-12-21 2016-12-21 A kind of vagina antibiosis pharmaceutical gel

Country Status (1)

Country Link
CN (1) CN106540046A (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112316050A (en) * 2020-11-09 2021-02-05 杭州宏果科技有限公司 Antibacterial nursing lotion and application thereof
CN112999294A (en) * 2019-12-19 2021-06-22 陕西康乐实业有限公司 Soft gel and preparation method and application thereof
CN113499403A (en) * 2021-07-13 2021-10-15 西安浩然药业有限责任公司 Formula and preparation method of gynecological traditional Chinese medicine pad

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102688182A (en) * 2012-06-04 2012-09-26 王洪明 Vagina pH buffer antibacterial gel and preparation method thereof

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102688182A (en) * 2012-06-04 2012-09-26 王洪明 Vagina pH buffer antibacterial gel and preparation method thereof

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112999294A (en) * 2019-12-19 2021-06-22 陕西康乐实业有限公司 Soft gel and preparation method and application thereof
CN112316050A (en) * 2020-11-09 2021-02-05 杭州宏果科技有限公司 Antibacterial nursing lotion and application thereof
CN113499403A (en) * 2021-07-13 2021-10-15 西安浩然药业有限责任公司 Formula and preparation method of gynecological traditional Chinese medicine pad

Similar Documents

Publication Publication Date Title
CN101347541B (en) Medicament for treating gynecology disease and dermatopathy and preparation thereof
CN102697961B (en) Gynecological cleaning solution and preparation method thereof
CN104224923A (en) Tea tree essential oil antimicrobial gel for treating vaginal disease in gynecology
CN102068640B (en) Externally-applied traditional Chinese medicine and preparation method thereof
CN100404054C (en) Decoction Chinese medicine sterilizing antiphlogistic, preparation and use thereof
CN102697671B (en) Bacterium and disease prevention wet wipe liquid medicament and preparation method thereof
CN102949501A (en) External washing lotion for treating gynecological inflammation
CN101269192A (en) Chinese medicinal composition for treating gynaecologic inflammation and preparation thereof
CN103385926A (en) Antibiosis gel for curing cervical and vaginal diseases of gynaecology
CN103316262B (en) A kind of gynecological external antibacterial liquid and preparation method thereof
CN109288889A (en) A kind of antibacterial gynecological composition, gel and preparation method thereof
CN106540046A (en) A kind of vagina antibiosis pharmaceutical gel
CN101744976A (en) Sterilizing and antipruritic lotion and preparation method thereof
CN102397444A (en) Nano-grade gynaecological lotion and preparation method thereof
CN101797269A (en) Physiological balance liquid for adjusting microecology in vaginas of women
CN101288754B (en) Huyuebao preparation
CN105362383A (en) Traditional Chinese medicine effervescent tablets for treating gynecologic inflammations and preparation method thereof
CN102631589A (en) Penyanxiao enema and preparation method thereof
CN110368447A (en) A kind of gynaecology's reparation gel preparation and its preparation method and application containing sodium azulenesulfonate
CN101143174A (en) Traditional Chinese medicine formula for treating cervical erosion
CN102988844A (en) Gynaecological gel and extraction method thereof
KR20120005260A (en) Cosmetic composition for feminine cleanser containing as active ingredient the fermented extract of rosa rugosa thunb
CN104474414B (en) A kind of medicine for treating gynaecological imflammation and preparation method thereof
WO2010021495A2 (en) Sanitary products
CN105311328A (en) Traditional Chinese medicine composition for treating gynecological inflammation and application thereof

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20170329